J&J’s HIV vaccine fails Phase 3 clinical trial

México Noticias Noticias

J&J’s HIV vaccine fails Phase 3 clinical trial
México Últimas Noticias,México Titulares
  • 📰 MarketWatch
  • ⏱ Reading Time:
  • 22 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 12%
  • Publisher: 97%

Johnson & Johnson’s experimental HIV vaccine is safe but not effective, and the late-stage study will be discontinued as a result of that finding, federal...

Johnson & Johnson’s JNJ experimental HIV vaccine is safe but not effective, and the late-stage study will be discontinued as a result of that finding, federal researchers said Wednesday. J&J’s stock was down 1.1% in trading on Wednesday afternoon. The vaccine was being tested in a Phase 3 clinical trial that enrolled 3,900 men who have sex with men and transgender people in several countries, including the U.S.

... Johnson & Johnson’s JNJ experimental HIV vaccine is safe but not effective, and the late-stage study will be discontinued as a result of that finding, federal researchers said Wednesday. J&J’s stock was down 1.1% in trading on Wednesday afternoon. The vaccine was being tested in a Phase 3 clinical trial that enrolled 3,900 men who have sex with men and transgender people in several countries, including the U.S.

Hemos resumido esta noticia para que puedas leerla rápidamente. Si estás interesado en la noticia, puedes leer el texto completo aquí. Leer más:

MarketWatch /  🏆 3. in US

México Últimas Noticias, México Titulares

Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.

PolitiFact - Magic Johnson did not contract HIV from a contaminated vaccinePolitiFact - Magic Johnson did not contract HIV from a contaminated vaccineJudy Mikovitz, a controversial virologist responsible for anti-vaccine conspiracies, claimed that Magic Johnson contracted HIV in 1991 from a contaminated Hepatitis B vaccine. That’s wildly untrue.
Leer más »

Johnson & Johnson slashes production on COVID vaccine amid drop in demandJohnson & Johnson slashes production on COVID vaccine amid drop in demandThere were high hopes for J&J's single-dose shot. But now the company is cutting down on production.
Leer más »

Johnson & Johnson slashes production of COVID vaccine amid drop in demandJohnson & Johnson slashes production of COVID vaccine amid drop in demandThere were high hopes for J&J's single-dose shot. But now the company is cutting down on production.
Leer más »

J&J to discontinue HIV vaccine trialJ&J to discontinue HIV vaccine trialJohnson & Johnson said on Wednesday that it was pulling the plug on a late-stage global trial of an HIV vaccine after the shot was found ineffective at preventing infections.
Leer más »

Global Push to Treat HIV Leaves Children BehindGlobal Push to Treat HIV Leaves Children BehindAWENDO, Kenya — The stories the mothers tell when they gather at the Awendo Health Centre in western Kenya are a catalog of small failures, missed opportunities and devastating consequences. What unites the two dozen or so women who meet periodically, on wooden benches in a bare clinic room or under a tree in the courtyard, is their children: All have HIV. It has been two decades since efforts to prevent the transmission of HIV, the virus that causes AIDS, from mother to child during pregnancy a
Leer más »



Render Time: 2025-02-27 09:22:57